Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; and vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
IPO Year:
Exchange: NYSE
Website: centene.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/14/2025 | $33.00 | Sell | Goldman |
| 7/28/2025 | $38.00 | Overweight → Neutral | Cantor Fitzgerald |
| 7/23/2025 | $30.00 | Overweight → Equal Weight | Wells Fargo |
| 7/21/2025 | $33.00 | Buy → Hold | TD Cowen |
| 7/16/2025 | $30.00 | Neutral → Underperform | BofA Securities |
| 7/10/2025 | $33.00 | Overweight → Equal-Weight | Morgan Stanley |
| 7/2/2025 | $45.00 | Buy → Neutral | UBS |
| 7/2/2025 | $48.00 | Overweight → Neutral | Analyst |
| 6/9/2025 | $70.00 | Overweight | Morgan Stanley |
| 6/2/2025 | $65.00 | Overweight → Equal Weight | Barclays |
8-K - CENTENE CORP (0001071739) (Filer)
SCHEDULE 13G/A - CENTENE CORP (0001071739) (Subject)
10-Q - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
SCHEDULE 13G/A - CENTENE CORP (0001071739) (Subject)
8-K - CENTENE CORP (0001071739) (Filer)
10-Q - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
Fastest customizable press release news feed in the world
The investment backs a peer-mentorship convening and a new online workforce map to create clear pathways into mental-health jobs for local youth SACRAMENTO, Calif., Nov. 12, 2025 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and a company of Centene Corporation (NYSE:CNC), has awarded a $100,000 grant to the Sacramento County Office of Education (SCOE) to support two ground breaking initiatives aimed at improving youth behavioral health and strengthening the local mental health workforce pipeline. The investment will fund a
Wellcare Medicare Advantage plans will be available to more than 51 million beneficiaries in 32 states; Prescription Drug Plans will continue to be offered nationwide TAMPA, Fla., Nov. 12, 2025 /PRNewswire/ -- Wellcare, a Centene Corporation (NYSE: CNC) company offering a comprehensive range of Medicare products, is excited to announce the start of the 2026 Medicare Annual Enrollment Period (AEP), from Oct. 15, 2025, through Dec. 7, 2025. "Choosing the right Medicare plan is one of the most important decisions seniors make each year," said Charlene Zein, CEO of Sunshine Health
Medicare Advantage plans will be available to more than 51 million beneficiaries in 32 states; Prescription Drug Plans will continue to be offered nationwide New in 2026 Wellcare to transition Medicare-Medicaid Plans (MMPs) demonstrations to integrated Dual Eligible Special Needs Plans (D-SNPs) in five states COLUMBIA, S.C., Nov. 10, 2025 /PRNewswire/ -- Wellcare, a company offering a comprehensive range of Medicare products and the Medicare brand of Centene Corporation (NYSE:CNC), will offer Medicare Advantage (MA) to over 51 million beneficiaries in 32 states and Prescription Drug Plan (PDP) products to more than 8 million members across all 50 states. This includes 51 new counties across
In 2026, Wellcare will also expand coverage for individuals who qualify for both Medicare and Medicaid, providing access to more comprehensive care and benefits AUSTIN, Texas, Nov. 10, 2025 /PRNewswire/ -- Wellcare, Wellcare By Allwell, and Wellcare By Superior HealthPlan, the Medicare products offered by Superior HealthPlan, a company of Centene Corporation (NYSE:CNC), will be available in 205 counties across Texas in 2026. This includes the cities of Austin, Dallas, El Paso, Houston, San Antonio and several others. The 2026 Medicare Annual Enrollment Period (AEP) begins Oct. 15, 2025, and runs through Dec. 7, 2025. Texans who enroll by Dec. 7, 2025, will have coverage starting Jan. 1, 2026
During open enrollment, starting Nov. 1, residents can access affordable plans from Ambetter from Absolute Total Care statewide COLUMBIA, S.C., Nov. 10, 2025 /PRNewswire/ -- Ambetter from Absolute Total Care, a product offered by a Centene Corporation (NYSE: CNC) company, a leading healthcare enterprise that provides insurance to under-insured and uninsured populations through the Health Insurance Marketplace®, will offer a variety of affordable health insurance plans to South Carolina residents statewide for plan year 2026. The open enrollment period for the Health Insurance Marketplace runs from Nov. 1, 2025, through Jan. 15, 2026. Enroll by Dec. 15, 2025, for coverage starting Jan. 1, 202
Investment strengthens community food resources for families struggling to access healthy meals CHARLOTTE, N.C., Nov. 7, 2025 /PRNewswire/ -- Carolina Complete Health and Centene Foundation, the philanthropic arm of Centene Corporation (NYSE:CNC), today announced a strategic and timely investment aimed at addressing food insecurity across North Carolina. This initiative comes as millions of Americans face increasing challenges in accessing nutritious meals due to recent disruptions to the Supplemental Nutrition Assistance Program (SNAP) and the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC). According to the U.S. Department of Agriculture (USDA), food insecurit
As Illinois transitions to a new state-based marketplace, Ambetter of Illinois offers affordable health coverage options in 25 counties during open enrollment, starting Nov. 1. CHICAGO, Nov. 7, 2025 /PRNewswire/ -- Ambetter of Illinois, a product offered by a Centene Corporation (NYSE: CNC) company, a leading healthcare enterprise that provides insurance to under-insured and uninsured populations through Get Covered Illinois, will offer a variety of affordable health insurance plans to Illinois residents in 25 counties for plan year 2026. New for 2026, Illinois is moving fro
During open enrollment, starting Nov. 1, residents can access affordable Ambetter from Arizona Complete Health plans in nine counties. PHOENIX, Nov. 6, 2025 /PRNewswire/ -- Ambetter from Arizona Complete Health, a product offered by a Centene Corporation (NYSE:CNC) company, a leading healthcare enterprise that provides insurance to under-insured and uninsured populations through the Health Insurance Marketplace®, will offer a variety of affordable health insurance plans to Arizonans in nine counties for plan year 2026. The open enrollment period for the Health Insurance Marketplace runs from Nov. 1, 2025, through Jan. 15, 2026. Enroll by Dec. 15, 2025, for coverage starting Jan. 1, 2026.
Donations strengthen community food resources for families struggling to access healthy food CHICAGO, Nov. 6, 2025 /PRNewswire/ -- Meridian Health Plan of Illinois, Inc. (Meridian) and Centene Foundation, the philanthropic arm of Centene Corporation (NYSE:CNC), today announced a strategic and timely investment aimed at addressing food insecurity across Illinois. This initiative comes as millions of Americans face increasing challenges in accessing nutritious food due to recent disruptions to the Supplemental Nutrition Assistance Program (SNAP) and the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC). According to the U.S. Department of Agriculture (USDA), food in
Investment strengthens community food resources for families struggling to access healthy meals AUSTIN, Texas, Nov. 6, 2025 /PRNewswire/ -- Superior HealthPlan and Centene Foundation, the philanthropic arm of Centene Corporation (NYSE:CNC), today announced a strategic and timely investment aimed at addressing food insecurity across Texas. This initiative comes as millions of Americans face increasing challenges in accessing nutritious meals due to recent disruptions to the Supplemental Nutrition Assistance Program (SNAP) and the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC). According to the U.S. Department of Agriculture (USDA), food insecurity currently affe
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
3/A - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Goldman initiated coverage of Centene with a rating of Sell and set a new price target of $33.00
Cantor Fitzgerald downgraded Centene from Overweight to Neutral and set a new price target of $38.00
Wells Fargo downgraded Centene from Overweight to Equal Weight and set a new price target of $30.00
TD Cowen downgraded Centene from Buy to Hold and set a new price target of $33.00
BofA Securities downgraded Centene from Neutral to Underperform and set a new price target of $30.00
Morgan Stanley downgraded Centene from Overweight to Equal-Weight and set a new price target of $33.00
Analyst downgraded Centene from Overweight to Neutral and set a new price target of $48.00
UBS downgraded Centene from Buy to Neutral and set a new price target of $45.00
Morgan Stanley resumed coverage of Centene with a rating of Overweight and set a new price target of $70.00
Barclays downgraded Centene from Overweight to Equal Weight and set a new price target of $65.00
Live Leadership Updates
Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN, Texas, July 29, 2025 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace (the "Company"), today announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4th 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on t
Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO
ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members. Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnership models and the use of advanced analytics and technologies to scale g
New leadership role reflects Centene's focus on ICHRA growth ST LOUIS, Jan. 9, 2025 /PRNewswire/ -- Centene Corporation ("Centene") (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, is pleased to announce that Alan Silver has joined the organization as the President of its Ambetter Health Solutions business, which focuses on ICHRA (Individual Coverage Health Reimbursement Arrangements). This newly created role reflects Centene's belief that consumers increasingly will seek health insurance that offers transparency, customization, choice and convenience. ICHRA plans allow employees to shop on the individual Marketplace and choose the insurance plan
PEMBROKE PINES, Fla., Nov. 7, 2024 /PRNewswire/ -- Sunshine Health, Florida's largest managed care organization and a Centene Corporation company (NYSE:CNC), announced today Charlene Zein has been named Plan President and Chief Executive Officer, effective Nov. 3, 2024. Zein has nearly two decades of experience in the healthcare industry, including various leadership roles of increasing scope and responsibility at Sunshine Health since joining in 2019. She most recently served as Sunshine Health Chief Product President, where she had oversight of all of Sunshine Health's Medi
ST. LOUIS, Aug. 15, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today that it has appointed Thomas R. Greco to the Centene Board of Directors, effective Aug. 9, 2024. Mr. Greco's term will run through the Company's 2025 annual meeting of stockholders. The appointment of Mr. Greco expands Centene's Board of Directors to 11 members. Mr. Greco is a seasoned operator and executive who brings more than four decades of public company leadership and expertise to Centene. Over the course of his career, he has implemented growth strategies and fostered
TAMPA, Fla., July 31, 2024 /PRNewswire/ -- Big Brothers Big Sisters of America (BBBSA), the nation's preeminent one-to-one youth mentoring organization, today announced the election of its newest Board member, Centene Corporation [Centene] (NYSE:CNC) Executive Vice President (EVP) of External Affairs, Jonathan Dinesman. Centene, a leading healthcare enterprise focused on transforming the health of the communities it serves, has been a long-time partner of BBBSA. Dinesman oversees Federal and State Government Relations; Centene's political action committee; Public Policy; Strat
Current Wellcare President & CEO, Richard Fisher, will join the Operations leadership team under Centene Chief Operating Officer Susan Smith, bringing additional Medicare expertise into Centene's core services operations ST. LOUIS, Jan. 22, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced two appointments. Michael A. Carson joins Centene as President and Chief Executive Officer (CEO) of its Medicare business, Wellcare. Mr. Carson will be responsible for Medicare business performance, strategy and growth and will report to Centene President Ken Fasola. Carson succeeds Richard Fisher, who has
PA Health & Wellness Safe & Sound Program to provide assistance with critical home repairs in Greater Harrisburg area HARRISBURG, Pa., Dec. 11, 2023 /PRNewswire/ -- PA Health & Wellness (PHW), a wholly owned subsidiary of Centene Corporation (NYSE:CNC), and Centene Foundation, the philanthropic arm of Centene Corporation, today announced its new partnership with Habitat for Humanity of the Greater Harrisburg Area to provide critical home repairs to area homeowners as part of the organization's Critical Home Repair program. The new program – PHW Safe & Sound – will cover the cost of eligible interior and exterior structural, electrical, plumbing, HVAC and other critical home repairs so that
Proctor brings more than 20 years of healthcare industry experience and proven leadership to Nebraska Total Care OMAHA, Neb., Nov. 16, 2023 /PRNewswire/ -- Nebraska Total Care, a leading provider of government-sponsored healthcare plans in Nebraska and wholly owned subsidiary of Centene Corporation (NYSE:CNC), announced today that Adam Proctor has been appointed as Plan President and Chief Executive Officer, effective November 19, 2023. Proctor replaces Heath Phillips, who was appointed to President and CEO overseeing Centene's Medicaid, Medicare and Marketplace offerings in Tennessee including Rhythm Health, Wellcare of Tennessee and Ambetter of Tennessee.
This live feed shows all institutional transactions in real time.
SC 13G - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
Live finance-specific insights
-- GAAP Diluted Loss Per Share of $(13.50); Adjusted Diluted Earnings Per Share of $0.50 -- Adjusted diluted EPS of $0.50 in the third quarter of 2025, including a $0.10 benefit of a low adjusted effective tax rate in the quarter as compared to the expected full year adjusted effective tax rate of 20-21%.$6.7 billion non-cash goodwill impairment, resulting in a GAAP loss and corresponding reduction of retained earnings in the third quarter of 2025. After the reduction to retained earnings, the debt-to-capital ratio was 45.5% at September 30, 2025.Medicaid HBR of 93.4% in the third quarter, including an approximate 40 basis point benefit from a retroactive revenue adjustment attributed to the
ST. LOUIS, Sept. 29, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 third quarter financial results at approximately 6:00 a.m. ET on Wednesday, October 29, 2025, and host a conference call at 9:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 0266211 to ex
-- Diluted Loss Per Share of $(0.51); Adjusted Diluted Loss Per Share of $(0.16) -- ST. LOUIS, July 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the second quarter ended June 30, 2025. In summary, the 2025 second quarter results were as follows: Total revenues (in millions) $ 48,742 Premium and service revenues (in millions) $ 42,467 Health benefits ratio 93.0 % SG&A expense ratio 7.1 % Adjusted SG&A expense ratio (1) 7.1 % GAAP diluted loss per share $ (0.51) Adjusted diluted loss per share (1) $ (0.16) Total cash flow provided by operations (in millions) $
CALL MOVED TO 8AM ET ST. LOUIS, July 22, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 second quarter financial results at approximately 6:00 a.m. ET on Friday, July 25, 2025, and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 7878291 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com,
-- Diluted EPS of $2.63; Adjusted Diluted EPS of $2.90 -- First quarter 2025 adjusted diluted EPS of $2.90, up 28% from $2.26 in the first quarter of 2024.17% year-over-year premium and service revenue growth.Membership increases of 29% in Marketplace and 22% in Medicare PDP, compared to the first quarter of 2024.Increased 2025 premium and service revenues guidance by $6.0 billion driven by outperformance in Marketplace enrollment and Medicare member retention.ST. LOUIS, April 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the first quarter ended March 31, 2025. In summary, the 2025 first quarter results were as follows: Total
ST. LOUIS, March 18, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 first quarter financial results at approximately 6:00 a.m. ET on Friday, April 25, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 9776439 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors
-- 2024 Full Year Diluted EPS of $6.31; Adjusted Diluted EPS of $7.17 -- 2024 adjusted diluted EPS of $7.17, up 7% from $6.68 in 2023.Membership increases of 12% in Marketplace and 50% in Medicare PDP, compared to the fourth quarter of 2023.Executed on capital deployment with $3.0 billion of share repurchases in 2024.Increased 2025 premium and service revenues guidance by $4.0 billion driven by Medicaid revenue and better than expected membership performance during the annual enrollment period in Medicare Advantage and PDP.ST. LOUIS, Feb. 4, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the fourth quarter and year ended December
ST. LOUIS, Jan. 15, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 fourth quarter and year-end financial results at approximately 6:00 a.m. ET on Tuesday, February 4, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 1342288 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, unde
-- 2025 adjusted diluted EPS of greater than $7.25 -- -- Reaffirms 2024 adjusted diluted EPS guidance of greater than $6.80 -- ST. LOUIS, Dec. 12, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company"), a leading healthcare enterprise committed to helping people live healthier lives, today will host its investor day to outline its 2025 financial guidance. "Centene is a mission driven organization, dedicated to delivering high quality outcomes for more than 28 million members, many of whom are among the nation's most medically complex and historically underserved populations. Over the last three years we improved our core operations and invested in the experience of our customer
-- Diluted EPS of $1.36; Adjusted Diluted EPS of $1.62 -- -- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 -- Adjusted diluted EPS of $1.62 in the third quarter of 2024.Premium and service revenues of $36.9 billion in the third quarter of 2024.Membership increases of 22% in Marketplace and 49% in Medicare Prescription Drug Plans, compared to the third quarter of 2023.Continued execution on capital deployment with $1.2 billion of share repurchases during the third quarter of 2024 and an additional $380 million in October, bringing full-year repurchases to $2.4 billion through October 2024.ST. LOUIS, Oct. 25, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the